Rostami S

No ORCID on file · 4 papers in corpus
2026
Astaxanthin Therapy in Women with Advanced Endometriosis: A Randomized Controlled Trial with Exploratory Analysis of Endometrial Wnt/β-Catenin Signaling
·doi:10.21203/rs.3.rs-8971122/v1

Abstract Background Endometriosis is a chronic gynecological disorder associated with pelvic pain and infertility, characterized by molecular and cellular dysregulation in the eutopic endometrium. Aberrant Wnt/β-catenin signaling has been…

2024
Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.
Journal of ovarian research ·doi:10.1186/s13048-024-01537-7

BackgroundPoor ovarian response (POR) to controlled ovarian stimulation (COS) remains challenging, especially in advanced-age women with diminished ovarian reserve, resulting in low live birth rates. Many patients prefer to conceive with th…

rct 2023
Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1144323

PURPOSE: In a randomized, triple-blind, placebo-controlled clinical trial (RCT) including 50 infertile women with endometriosis candidate for assisted reproductive techniques (ART), we studied the effect of Astaxanthin (AST) on pro-inflamma…

article 2023
High Anti-Müllerian Hormone Strongly Correlates with Reproductive Outcomes in Women Undergoing Assisted Reproduction
Clinical laboratory ·doi:10.7754/clin.lab.2023.230524

BACKGROUND: In a retrospective cohort of 881 women with gynecologic and unexplained infertility, we aimed to study the relationship between serum AMH levels and ART outcomes. This retrospective cohort includes 881 infertile women aged 20 - …